The largest database of trusted experimental protocols

82 protocols using finometer

1

Hemodynamic and Skin Blood Flow Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
We measured the hemodynamic parameters using Finometer ® (Finapres Medical Systems, FMS, Arnhem, Netherlands), including heart rate (HR), SBP, diastolic blood pressure (DBP), stroke volume (SV), cardiac index (CI), and total peripheral vascular resistance (TPR).[ 21 ] One-minute average of the hemodynamic parameters was collected from the continuous recording of Finometer ® . Skin blood flow was measured in the other hand by a laser Doppler flowmeter (DRT4 Instrument, Moor Instruments, Devon, UK).
+ Open protocol
+ Expand
2

Measuring Cardiovascular Responses in Supine

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heart rate (HR) was monitored with a 3‐lead ECG. Mean arterial pressure (MAP) was measured by placing a finger pressure cuff around the middle phalanx of the middle finger on the nonexperimental arm, which remained at heart level (supine position) throughout the measurement (Finometer; Finapres Medical Systems BV, Amsterdam, The Netherlands). Resting arterial blood pressure was measured over the brachial artery following 30 min of supine rest and just prior to each exercise trial (Cardiocap 5; Datex Ohmeda, Louisville, CO), and resting Finometer MAP was corrected for differences between the two readings (Kirby et al. 2005).
+ Open protocol
+ Expand
3

Multimodal Cardiovascular Monitoring Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Instrumentation for each experiment was identical. Heart rate was continuously obtained from an electrocardiogram (HP Patient Monitor, Agilent, Santa Clara, CA, USA) interfaced with a cardiotachometer (CWE, Ardmore, PA, USA). Continuous beat-by-beat MAP was recorded from a finger using the Penaz method [Finometer; Finapres Medical Systems, Amsterdam, The Netherlands (experiment 1) and the CNAP, Biopac Monitor 500, Bruck an der Mur Austria (experiment 2)] and was corrected according to intermittent blood pressure measurements obtained by auscultation of the brachial artery via electrosphygmomanometry (SunTech, Raleigh, NC, USA). Blood flow in the middle cerebral artery (CBFV) was continuously measured using transcranial Doppler ultrasonography. A 2 MHz Doppler probe (Multi-flow; DWL Elektronische Systeme, Singen, Germany) was adjusted over the temporal window of the right middle cerebral artery until an optimal signal was identified. The probe was then fixed and held in place using a headband strap to prevent subtle movement of the Doppler probe. An index of cerebrovascular conductance (CVCI) was calculated from the ratio of CBFV to MAP. The was measured continuously using a capnograph (VitalCap Capnograph Monitor; Oridion, Needham, MA, USA).
+ Open protocol
+ Expand
4

Multimodal Cardiovascular and Cerebrovascular Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
Instrumentation for each aim was identical. Heart rate was continuously obtained from an electrocardiogram (HP Patient Monitor, Agilent, Santa Clara, CA) interfaced with a cardiotachometer (CWE, Ardmore, PA). Continuous beat-by-beat mean arterial blood pressure (MAP) was recorded from a finger using the Penaz method (Finometer, Finapres Medical Systems, Amsterdam, Netherlands (aim #1) and the CNAP, Biopac Monitor 500, Austria (aim #2)) and was corrected according to intermittent blood pressure measurements obtained by auscultation of the brachial artery via electrosphygmomanometry (SunTech, Raleigh, NC). Blood flow in the middle cerebral artery (CBFV) was continuously measured using transcranial Doppler ultrasonography. A 2-MHz Doppler probe (Multi-flow, DWL Elektronische Systeme, Singen, Germany) was adjusted over the temporal window of the right middle cerebral artery until an optimal signal was identified. The probe was then fixed and held in place using a headband strap to prevent subtle movement of the Doppler probe. An index of cerebrovascular conductance (CVCI) was calculated from the ratio of CBFV to MAP. PETCO2 was continuously measured using a capnograph (VitalCap Capnograph Monitor, Oridion, Needham, MA).
+ Open protocol
+ Expand
5

Sympathetic Nerve Activity and Cardiovascular Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
Continuous measurements of muscle sympathetic nerve activity (MSNA), blood pressure, and heart rate were made throughout the protocol. Sympathetic nerve recordings were obtained in the right peroneal nerve by microneurography (Hagbarth and Vallbo, 1968 (link)), using methods from our laboratory described previously in detail (Kimmerly and Shoemaker, 2003 (link); Kimmerly et al., 2004 (link); Badrov et al., 2015 (link); Usselman et al., 2015 (link)). Beat-to-beat blood pressure was measured using finger photoplethysmography (Finometer; Finapres Medical Systems, Amsterdam, The Netherlands). Blood pressure values obtained from the Finometer were calibrated to the average of three baseline blood pressure measurements assessed using manual sphygmomanometry. Heart rate was measured throughout using a standard three-lead electrocardiogram. All data were collected and analyzed offline using PowerLab/16SP with LabChart 6 (ADInstruments, Colorado Springs, Colorado, USA). Typical measurements from one subject are shown in Figure 1.
+ Open protocol
+ Expand
6

Renal Nerve Ablation Cardiovascular Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
The study protocol at 12 months after renal nerve ablation was exactly the same as 6 months after renal nerve ablation.[5 (link)] During testing, patients remained in the supine position. An ECG was continuously recorded (Niccomo, Medis GmbH, Germany). Noninvasive finger blood pressure recording was used (Finometer, Finapres Medical Systems, NL) and adjusted against brachial oscillometric blood pressure measurements (Dinamap, Critikon, USA).
+ Open protocol
+ Expand
7

Noninvasive Hemodynamic Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
In both studies, mean arterial pressure (MAP) was measured noninvasively using photoelectric plethysmography with a Finometer (Finapres Medical Systems BV, Arnhem, Netherlands), which was calibrated with upper cuff and height adjustment. Furthermore, HR and stroke volume, hence cardiac output (CO), were determined from the blood pressure waveform using the Modelflow software program (BeatScope 1.1, Finapres Medical Systems BV, Amhem, Netherlands), which takes into account the participant's sex, age, height, and weight.
+ Open protocol
+ Expand
8

Comprehensive Physiological Monitoring Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
HR was monitored via a three‐lead electrocardiogram. Arterial blood pressure was measured non‐invasively using finger photoplethysmography (Finometer, Finapres Medical Systems). The monitoring cuff was placed around the middle finger of the right hand, with the forearm and hand supported so that the cuff was at the vertical level of the heart. Core temperature (Tc) was assessed using a commercially available rectal probe (RET‐1, Physitemp Instruments) inserted 15 cm past the sphincter muscle and connected to a thermocouple meter (TC‐2000, Sable Systems). Mean skin temperature (Tsk) from four sites (standard weightings of chest, arm, thigh, and calf, (Ramanathan, 1964)) was obtained using a wireless monitoring system (iButton®, Maxim Integrated). Analog signals of the electrocardiogram, blood pressure waveform, and Tc were sampled at 1,000 Hz using a data acquisition unit (Powerlab 16/30, ADInstruments) and analyzed using an off‐line data analysis software (LabChart 8, ADInstruments).
+ Open protocol
+ Expand
9

Continuous Arterial Pressure Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
Beat-to-beat systolic (SAP), diastolic (DAP), and mean (MAP) arterial pressures were measured continuously using a volume-clamp technique (Finometer, Finapres Medical Systems BV, Amsterdam, The Netherlands), with the pressure cuff placed around the middle phalanx of the left middle finger, and with the reference pressure transducer positioned at the level of the heart. The Finometer-derived values were verified intermittently by electro-sphygmomanometry (Omron, M6, Kyoto, Japan). HR was derived from the arterial pressure curves as the inverse of the interbeat interval.
+ Open protocol
+ Expand
10

Hemodynamic and Muscle Activity Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
An electrocardiogram (ECG) was monitored with a telemetry system (DynaScope DS‐3140; Fukuda Denshi, Tokyo, Japan). Arterial blood pressure (AP) was noninvasively and continuously measured with a Finometer® (Finapres Medical Systems BV, Arnhem, the Netherlands), whose cuff was attached to the left middle finger. The AP waveform was sampled at a frequency of 200 Hz. The beat‐to‐beat values of systolic, diastolic, and MAP and heart rate (HR) were obtained throughout the experiments. Simultaneously, the beat‐to‐beat values of cardiac output (CO), stroke volume (SV), and total peripheral resistance (TPR) were calculated from the aortic pressure waveform using a Modelflow® software (BeatScope 1.1; Finapres Medical Systems BV, Arnhem, the Netherlands). The reliability of the CO measurement using the Modelflow® has been confirmed previously (van Lieshout et al. 2003 (link); Matsukawa et al. 2004 (link); Tam et al. 2004 (link)).
Electromyogram (EMG) activity of the VL muscle was bilaterally measured using a pair of silver‐bar electrodes attached on the central portion of the muscle belly (Bagnoli‐2 EMG System, Delsys, Boston, MA). The EMG signals were amplified (×10,000) and passed through a bandpass filter between 20 and 2000 Hz.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!